title: How critical is the blood-brain barrier to the development of neurotherapeutics?
authors: Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, Maryland.
authors: Carmen
authors: C
authors: Kut
authors: Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.
authors: Stuart A
authors: SA
authors: Grossman
authors: Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland3Departments of Neurology and Neurosurgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Mar.
authors: Jaishri
authors: J
authors: Blakeley
mesh_terms: D001812:Blood-Brain Barrier / Q000187:drug effects* / Q000503:physiopathology; D002490:Central Nervous System / Q000187:drug effects* / Q000473:pathology; D002493:Central Nervous System Diseases / Q000188:drug therapy; D016503:Drug Delivery Systems; D055808:Drug Discovery / Q000191:economics; D006801:Humans
references: N Engl J Med. 1971 Feb 25;284(8):412-5
references: 5540479
references: Ann Neurol. 1983 Sep;14(3):316-24
references: 6195955
references: Magn Reson Med. 1991 Feb;17(2):357-67
references: 2062210
references: Sci Rep. 2013;3:2859
references: 24091529
references: HIV Med. 2010 Apr;11(4):276-81
references: 20002501
references: J Clin Oncol. 2007 Jun 1;25(16):2295-305
references: 17538176